<Legislation xmlns="http://www.legislation.gov.uk/namespaces/legislation" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" DocumentURI="http://www.legislation.gov.uk/nisr/2021/342/made" IdURI="http://www.legislation.gov.uk/id/nisr/2021/342" NumberOfProvisions="2" xsi:schemaLocation="http://www.legislation.gov.uk/namespaces/legislation http://www.legislation.gov.uk/schema/legislation.xsd" SchemaVersion="1.0"><ukm:Metadata xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:ukm="http://www.legislation.gov.uk/namespaces/metadata">
					<dc:identifier>http://www.legislation.gov.uk/nisr/2021/342/note/made</dc:identifier><dc:title>The Misuse of Drugs (Amendment No. 2) Regulations (Northern Ireland) 2021</dc:title><dc:language>en</dc:language><dc:publisher>Government Printer for Northern Ireland</dc:publisher><dc:modified>2021-12-17</dc:modified><dc:subject scheme="SIheading">DANGEROUS DRUGS</dc:subject>
					<dc:description>These Regulations amend the Misuse of Drugs Regulations (Northern Ireland) 2002 (S.R. 2002 No. 1) (“the Regulations”).</dc:description>
					<atom:link rel="self" href="http://www.legislation.gov.uk/nisr/2021/342/note/made/data.xml" type="application/xml"/><atom:link rel="http://www.legislation.gov.uk/def/navigation/resources" href="http://www.legislation.gov.uk/nisr/2021/342/resources" title="More Resources"/>
					
					<atom:link rel="http://www.legislation.gov.uk/def/navigation/memorandum" href="http://www.legislation.gov.uk/nisr/2021/342/memorandum" title="Explanatory Memorandum"/><atom:link rel="http://www.legislation.gov.uk/def/navigation/memorandum/toc" href="http://www.legislation.gov.uk/nisr/2021/342/memorandum/contents" title="Explanatory Memorandum Table of Contents"/>
					
					<atom:link rel="http://www.legislation.gov.uk/def/navigation/act" href="http://www.legislation.gov.uk/nisr/2021/342/made" title="whole act"/><atom:link rel="http://www.legislation.gov.uk/def/navigation/introduction" href="http://www.legislation.gov.uk/nisr/2021/342/introduction/made" title="introduction"/><atom:link rel="http://www.legislation.gov.uk/def/navigation/signature" href="http://www.legislation.gov.uk/nisr/2021/342/signature/made" title="signature"/><atom:link rel="http://www.legislation.gov.uk/def/navigation/note" href="http://www.legislation.gov.uk/nisr/2021/342/note/made" title="note"/>
					<atom:link rel="http://www.legislation.gov.uk/def/navigation/body" href="http://www.legislation.gov.uk/nisr/2021/342/body/made" title="body"/>
					
					
										
					
					
					
					<atom:link rel="alternate" type="application/rdf+xml" href="http://www.legislation.gov.uk/nisr/2021/342/note/made/data.rdf" title="RDF/XML"/><atom:link rel="alternate" type="application/akn+xml" href="http://www.legislation.gov.uk/nisr/2021/342/note/made/data.akn" title="AKN"/><atom:link rel="alternate" type="application/xhtml+xml" href="http://www.legislation.gov.uk/nisr/2021/342/note/made/data.xht" title="HTML snippet"/><atom:link rel="alternate" type="text/html" href="http://www.legislation.gov.uk/nisr/2021/342/note/made/data.htm" title="Website (XHTML) Default View"/><atom:link rel="alternate" type="text/csv" href="http://www.legislation.gov.uk/nisr/2021/342/note/made/data.csv" title="CSV"/><atom:link rel="alternate" type="application/pdf" href="http://www.legislation.gov.uk/nisr/2021/342/note/made/data.pdf" title="PDF"/>
					<atom:link rel="alternate" type="application/akn+xhtml" href="http://www.legislation.gov.uk/nisr/2021/342/note/made/data.html" title="HTML5 snippet"/>

					
					<atom:link rel="http://purl.org/dc/terms/tableOfContents" hreflang="en" href="http://www.legislation.gov.uk/nisr/2021/342/contents/made" title="Table of Contents"/>
					
					<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/nisr/2021/342/note" title="current"/>
					
					<atom:link rel="up" href="http://www.legislation.gov.uk/nisr/2021/342/made" title="Entire legislation"/><atom:link rel="prev" href="http://www.legislation.gov.uk/nisr/2021/342/signature/made" title="Signature; Signature"/><atom:link rel="prevInForce" href="http://www.legislation.gov.uk/nisr/2021/342/signature/made" title="Signature; Signature"/>
					<ukm:SecondaryMetadata><ukm:DocumentClassification>
<ukm:DocumentCategory Value="secondary"/>
<ukm:DocumentMainType Value="NorthernIrelandStatutoryRule"/>
<ukm:DocumentStatus Value="final"/>
<ukm:DocumentMinorType Value="regulation"/>
</ukm:DocumentClassification><ukm:Year Value="2021"/><ukm:Number Value="342"/><ukm:Made Date="2021-12-15"/><ukm:ComingIntoForce>
<ukm:DateTime Date="2022-06-15"/></ukm:ComingIntoForce><ukm:ISBN Value="9780338017925"/><ukm:UnappliedEffects><ukm:UnappliedEffect AffectingProvisions="reg. 1(1)" AffectedURI="http://www.legislation.gov.uk/id/nisr/2021/342" AffectingClass="NorthernIrelandStatutoryRule" Notes="I note removed for commencement as SR 2021 342 revoked by SR 2022 176 on 14/6/2022" URI="http://www.legislation.gov.uk/id/effect/key-18e1ba18167a9c9793dbe30f195ad893" AffectedExtent="N.I." AffectedYear="2021" AffectingURI="http://www.legislation.gov.uk/id/nisr/2021/342" Row="5" AffectingYear="2021" AppliedModified="2022-09-13T08:09:34.93004+01:00" Modified="2022-09-13T09:34:12Z" EffectId="key-18e1ba18167a9c9793dbe30f195ad893" RequiresApplied="false" Type="coming into force" AffectedNumber="342" AffectingNumber="342" AffectedClass="NorthernIrelandStatutoryRule" AffectedProvisions="reg. 1"><ukm:AffectedTitle>The Misuse of Drugs (Amendment No. 2) Regulations (Northern Ireland) 2021 (revoked)</ukm:AffectedTitle><ukm:AffectedTitle>The Misuse of Drugs (Amendment No. 2) Regulations (Northern Ireland) 2021</ukm:AffectedTitle><ukm:AffectedProvisions><ukm:Section Ref="regulation-1" URI="http://www.legislation.gov.uk/id/nisr/2021/342/regulation/1">reg. 1</ukm:Section></ukm:AffectedProvisions><ukm:AffectingTitle>The Misuse of Drugs (Amendment No. 2) Regulations (Northern Ireland) 2021 (revoked)</ukm:AffectingTitle><ukm:AffectingTitle>The Misuse of Drugs (Amendment No. 2) Regulations (Northern Ireland) 2021</ukm:AffectingTitle><ukm:AffectingProvisions><ukm:Section Ref="regulation-1-1" URI="http://www.legislation.gov.uk/id/nisr/2021/342/regulation/1/1">reg. 1(1)</ukm:Section></ukm:AffectingProvisions><ukm:InForceDates><ukm:InForce Date="2022-06-15" Qualification="wholly in force"/></ukm:InForceDates></ukm:UnappliedEffect><ukm:UnappliedEffect AffectingProvisions="reg. 1(1)" AffectedClass="NorthernIrelandStatutoryRule" Modified="2022-09-13T09:34:12Z" URI="http://www.legislation.gov.uk/id/effect/key-949d6818c7153759226684130af63b15" AffectedExtent="N.I." Notes="I note removed for commencement as SR 2021 342 revoked by SR 2022 176 on 14/6/2022" AppliedModified="2022-09-13T08:09:34.93004+01:00" AffectingNumber="342" AffectedProvisions="reg. 2" AffectingClass="NorthernIrelandStatutoryRule" Type="coming into force" AffectingURI="http://www.legislation.gov.uk/id/nisr/2021/342" AffectedURI="http://www.legislation.gov.uk/id/nisr/2021/342" AffectingYear="2021" Row="6" AffectedYear="2021" AffectedNumber="342" RequiresApplied="false" EffectId="key-949d6818c7153759226684130af63b15"><ukm:AffectedTitle>The Misuse of Drugs (Amendment No. 2) Regulations (Northern Ireland) 2021 (revoked)</ukm:AffectedTitle><ukm:AffectedTitle>The Misuse of Drugs (Amendment No. 2) Regulations (Northern Ireland) 2021</ukm:AffectedTitle><ukm:AffectedProvisions><ukm:Section Ref="regulation-2" URI="http://www.legislation.gov.uk/id/nisr/2021/342/regulation/2">reg. 2</ukm:Section></ukm:AffectedProvisions><ukm:AffectingTitle>The Misuse of Drugs (Amendment No. 2) Regulations (Northern Ireland) 2021 (revoked)</ukm:AffectingTitle><ukm:AffectingTitle>The Misuse of Drugs (Amendment No. 2) Regulations (Northern Ireland) 2021</ukm:AffectingTitle><ukm:AffectingProvisions><ukm:Section Ref="regulation-1-1" URI="http://www.legislation.gov.uk/id/nisr/2021/342/regulation/1/1">reg. 1(1)</ukm:Section></ukm:AffectingProvisions><ukm:InForceDates><ukm:InForce Date="2022-06-15" Qualification="wholly in force"/></ukm:InForceDates></ukm:UnappliedEffect></ukm:UnappliedEffects></ukm:SecondaryMetadata>
					

                    
									<ukm:Notes><ukm:Note IdURI="http://www.legislation.gov.uk/id/nisr/2021/342/notes"/><ukm:Alternatives><ukm:Alternative URI="http://www.legislation.gov.uk/nisr/2021/342/pdfs/nisrem_20210342_en.pdf" Date="2021-12-17" Title="NI Explanatory Memorandum" Size="35737"/></ukm:Alternatives>       
								</ukm:Notes> 
					<ukm:Alternatives><ukm:Alternative URI="http://www.legislation.gov.uk/nisr/2021/342/pdfs/nisr_20210342_en.pdf" Date="2021-12-17" Size="36261"/></ukm:Alternatives>
					
					<ukm:Statistics>
									<ukm:TotalParagraphs Value="2"/>
									<ukm:BodyParagraphs Value="2"/>
									<ukm:ScheduleParagraphs Value="0"/>
									<ukm:AttachmentParagraphs Value="0"/>
									<ukm:TotalImages Value="0"/>
								</ukm:Statistics>
				</ukm:Metadata><Secondary><ExplanatoryNotes DocumentURI="http://www.legislation.gov.uk/nisr/2021/342/note/made" IdURI="http://www.legislation.gov.uk/id/nisr/2021/342/note">
<Title>EXPLANATORY NOTE</Title>
<Comment>
<Para><Text>(This note is not part of the Regulations)</Text></Para>
</Comment>
<P><Text>These Regulations amend the Misuse of Drugs Regulations (Northern Ireland) 2002 (<Citation URI="http://www.legislation.gov.uk/id/nisr/2002/1" id="c00001" Class="NorthernIrelandStatutoryRule" Year="2002" Number="0001">S.R. 2002 No. 1</Citation>) (“<Term>the Regulations</Term>”).</Text></P>
<P><Text>Regulation 2(2) removes regulation 4B of the Regulations, that made it lawful to import, export, produce, supply, offer to supply or possess Gamma-butyrolactone (GBL) and 1,4-Butanediol (1,4-BD) in certain circumstances.</Text></P>
<P><Text>Regulation 2(3) adds 1,4-Butanediol (1,4-BD) and Gamma-butyrolactone (GBL) to Schedule 1 to the Regulations. The Schedule to the Regulations in which a controlled drug is placed affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed. The controlled drugs placed in Schedule 1 to the Regulations are those subject to the tightest controls, requiring a licence in order to access such drugs.</Text></P>
</ExplanatoryNotes></Secondary></Legislation>